Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 9/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3770838 | 0.93 | PPARA (0.48) | MAOBPPARATSHRDHFRKDM4E | |
| SCHEMBL3764368 | 0.91 | PPARA (0.50) | MAOBPPARATSHRDHFRGGPS1 | |
| SCHEMBL3657459 | 0.91 | MAOB (0.43) | MAOBPPARATSHRDHFRKDM4E | |
| SCHEMBL3771346 | 0.88 | AOC3 (0.44) | MAOBPPARADHFRNOS1NOS2 | |
| SCHEMBL3763398 | 0.86 | MAOB (0.44) | MAOBTSHRDHFRKDM4EALDH1A1 | |
| SCHEMBL17138141 | 0.85 | TSHR (0.46) | PPARATSHR | |
| SCHEMBL17138142 | 0.85 | TSHR (0.46) | PPARATSHR | |
| SCHEMBL2538910 | 0.84 | DHFR (0.54) | MAOBTSHRDHFRKDM4EALDH1A1 | |
| SCHEMBL3660582 | 0.84 | PPARA (0.45) | MAOBPPARATSHRDHFRKDM4E | |
| SCHEMBL3769700 | 0.82 | PPARA (0.47) | MAOBPPARATSHRDHFRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | MAOB 667/4885PPARA 1791/4885TSHR 811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.